_PRIVATE_LIMITED.webp)
Organz Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 29-05-2024
- Paid Up Capital ₹ 0.60 M
as on 29-05-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 29-05-2024
- Revenue -27.04%
(FY 2021)
- Profit -83.15%
(FY 2021)
- Ebitda 1.24%
(FY 2021)
- Net Worth 1.44%
(FY 2021)
- Total Assets 20.38%
(FY 2021)
About Organz Biotech (India)
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹5.00 M.
Abdul Thanuba and Sharmila serve as directors at the Company.
- CIN/LLPIN
U24233MH2010PTC209484
- Company No.
209484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Organz Biotech (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abdul Thanuba  | Director | 08-May-2019 | Current |
| Sharmila | Director | 08-May-2019 | Current |
Financial Performance and Corporate Structure Insights of Organz Biotech (India).
Organz Biotech (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 27.04% decrease. The company also saw a substantial fall in profitability, with a 83.15% decrease in profit. The company's net worth moved up by a moderate rise of 1.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Organz Biotech (India)?
Unlock access to Organz Biotech (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Organz Biosciences Private Limited
Active
4 years 1 month Abdul Thanuba and Sharmila are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jul 2022 | ₹5.00 M | Open |
How Many Employees Work at Organz Biotech (India)?
Unlock and access historical data on people associated with Organz Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Organz Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Organz Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
